Clinical Data's Q4 Revenue Doubles as Net Loss Widens | GenomeWeb

NEW YORK (GenomeWeb News) – Clinical Data today reported that its fiscal fourth-quarter revenues doubled year over year as its quarterly net loss grew by 62 percent.

Revenue for the three months ended March 31 climbed 103 percent to $3.2 million from $1.6 million in the comparable period of 2008. The company attributed the increase to the expansion of its PGxHealth sales and marketing force and increased payor coverage during the last 18 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.